[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@equity_pulse_](/creator/twitter/equity_pulse_) "$REPL announced that Dr. Caroline Robert presented new interim analysis data from the Phase X IGNYTE trial evaluating RP1 in combination with nivolumab at the 2025 ESMO Congress in Berlin" [X Link](https://x.com/equity_pulse_/status/1980258765090816506) [@equity_pulse_](/creator/x/equity_pulse_) 2025-10-20T13:04Z 3314 followers, XX engagements "Today I'm officially launching my 10K to 100K Trading Challenge Day trading strategies and setups will be shared daily in our WhatsApp group for free. Join us 👉 $CRM $AVGO $QCOM" [X Link](https://x.com/equity_pulse_/status/1980265292149264614) [@equity_pulse_](/creator/x/equity_pulse_) 2025-10-20T13:30Z 3254 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@equity_pulse_
"$REPL announced that Dr. Caroline Robert presented new interim analysis data from the Phase X IGNYTE trial evaluating RP1 in combination with nivolumab at the 2025 ESMO Congress in Berlin"
X Link @equity_pulse_ 2025-10-20T13:04Z 3314 followers, XX engagements
"Today I'm officially launching my 10K to 100K Trading Challenge Day trading strategies and setups will be shared daily in our WhatsApp group for free. Join us 👉 $CRM $AVGO $QCOM"
X Link @equity_pulse_ 2025-10-20T13:30Z 3254 followers, XXX engagements
/creator/twitter::1417787318/posts